Risk prediction of atrial fibrillation and its complications in the community using hs troponin I.
Christin S BörschelBastiaan GeelhoedTeemu NiiranenStephan CamenMaria Benedetta DonatiAki S HavulinnaFrancesco GianfagnaTarja TuovinenPekka JousilahtiJukka KonttoErkki VartiainenFrancisco M OjedaHester M den RuijterSimona CostanzoGiovanni de GaetanoAugusto Di CastelnuovoAllan LinnebergJulie K Vishram-NielsenMaja-Lisa LøchenWolfgang KoenigTorben JørgensenKari KuulasmaaStefan BlankenbergLicia IacovielloTanja ZellerStefan SöderbergVeikko SalomaaRenate B SchnabelPublished in: European journal of clinical investigation (2023)
hsTnI as a biomarker of myocardial injury does not improve prediction of AF incidence beyond classical CVRF and NT-proBNP. However, it is associated with the AF-related disease heart failure and mortality likely reflecting underlying subclinical cardiovascular impairment.